Rezulin (troglitazone) tablets for Type II diabetes

March 1997

    Parke-Davis is now introducing Rezulin (troglitazone) tablets for Type II diabetes.

    This is the first drug in a new class...called "glitazones."

    Rezulin improves insulin sensitivity. It increases the uptake of glucose into muscle and adipose tissue...and decreases hepatic glucose production.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote